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Abstract. 
 
b
 
-Catenin is essential for the function of cad-
 
herins, a family of Ca
 
2
 
1
 
-dependent cell–cell adhesion 
molecules, by linking them to 
 
a
 
-catenin and the actin 
cytoskeleton. 
 
b
 
-Catenin also binds to adenomatous 
polyposis coli (APC) protein, a cytosolic protein that is 
the product of a tumor suppressor gene mutated in 
colorectal adenomas. We have expressed mutant 
 
b
 
-catenins in MDCK epithelial cells to gain insights 
into the regulation of 
 
b
 
-catenin distribution between 
cadherin and APC protein complexes and the functions 
of these complexes. Full-length 
 
b
 
-catenin, 
 
b
 
-catenin 
mutant proteins with NH
 
2
 
-terminal deletions before 
(
 
D
 
N90) or after (
 
D
 
N131, 
 
D
 
N151) the 
 
a
 
-catenin binding 
site, or a mutant 
 
b
 
-catenin with a COOH-terminal dele-
tion (
 
D
 
C) were expressed in MDCK cells under the 
control of the tetracycline-repressible transactivator. 
All 
 
b
 
-catenin mutant proteins form complexes and 
colocalize with E-cadherin at cell–cell contacts; 
 
D
 
N90, 
but neither 
 
D
 
N131 nor 
 
D
 
N151, bind 
 
a
 
-catenin. How-
ever, 
 
b
 
-catenin mutant proteins containing NH
 
2
 
-termi-
nal deletions also colocalize prominently with APC 
protein in clusters at the tips of plasma membrane pro-
trusions; in contrast, full-length and COOH-terminal–
deleted 
 
b
 
-catenin poorly colocalize with APC protein. 
NH
 
2
 
-terminal deletions result in increased stability of 
 
b
 
-catenin bound to APC protein and E-cadherin, com-
pared with full-length 
 
b
 
-catenin. At low density, 
MDCK cells expressing NH
 
2
 
-terminal–deleted 
 
b
 
-cate-
nin mutants are dispersed, more fibroblastic in mor-
phology, and less efficient in forming colonies than pa-
rental MDCK cells. These results show that the NH
 
2
 
 
terminus, but not the COOH terminus of 
 
b
 
-catenin, 
regulates the dynamics of 
 
b
 
-catenin binding to APC 
protein and E-cadherin. Changes in 
 
b
 
-catenin binding 
to cadherin or APC protein, and the ensuing effects 
on cell morphology and adhesion, are independent of 
 
b
 
-catenin binding to 
 
a
 
-catenin. These results demon-
strate that regulation of 
 
b
 
-catenin binding to E-cad-
herin and APC protein is important in controlling epi-
thelial cell adhesion.
 
b
 
-
 
Catenin 
 
is a ubiquitous protein in multicellular organ-
isms and was originally identified through its association
with the cytoplasmic domain of cadherins, a family of
Ca
 
2
 
1
 
-dependent cell adhesion proteins (McCrea and Gum-
biner, 1991; McCrea et al., 1991; Nagafuchi and Takeichi,
1989; Ozawa et al., 1989). Cadherin-mediated intercellular
adhesion initiates structural and functional changes in cells
and is important for maintaining tissue integrity during
embryonic development and in adult organisms (Nelson et
al., 1992; Takeichi, 1990, 1991). These functions of cadherin
require intracellular attachment of cadherin to the actin
cytoskeleton that is dependent on binding of cadherin to
catenins (Hirano et al., 1987; Nagafuchi and Takeichi,
1988; Ozawa et al., 1990); 
 
b
 
-catenin mediates the linkage
of cadherins to 
 
a
 
-catenin, which in turn interacts with the
actin cytoskeleton (Aberle et al., 1994; Hülsken et al.,
1994; Jou et al., 1995; Rimm et al., 1995).
Coordination of intercellular adhesion and cell migra-
tion is important during embryonic development. For ex-
ample, during gastrulation, neurulation, and organogene-
sis, sheets of cells move past neighboring cells without
losing cell–cell contact (Gumbiner, 1992). Significantly,
embryonic development of mice lacking 
 
b
 
-catenin is dis-
rupted at gastrulation (Haegel et al., 1995). These embryos
form a trophectoderm and develop through preimplanta-
tion stages presumably because of the contribution of ma-
ternal 
 
b
 
-catenin or replacement of 
 
b
 
-catenin in adherens
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junctions by its homologue plakoglobin. However, 
 
b
 
-cate-
nin–deficient embryos have severe defects in cell adhesion
at gastrulation (Haegel et al., 1995). It is also noteworthy
that human cancer cell lines expressing a mutated form
of 
 
b
 
-catenin, which binds E-cadherin but not 
 
a
 
-catenin,
are defective in E-cadherin–mediated adhesion (Oyama
et al., 1994). The importance of 
 
b
 
-catenin in embryogenesis
is also revealed in studies in 
 
Drosophila.
 
 A homologue of
 
b
 
-catenin in 
 
Drosophila
 
, armadillo, was originally identi-
fied through its role in transduction of the wingless/Wnt
cell–cell signal that mediates cell fate determination.
 
Drosophila
 
 embryos that are zygotically null for armadillo
develop with severe segment polarity defects (Noorder-
meer et al., 1994; Peifer et al., 1991; Peifer and Wieschaus,
1990; Siegfried et al., 1994). Similar to the requirement of
 
b
 
-catenin in vertebrate embryogenesis, armadillo is re-
quired for adherens junction assembly in 
 
Drosophila
 
 em-
bryogenesis. A combination of maternal and zygotic nulls
of armadillo disrupts formation of an organized epithe-
lium early in 
 
Drosophila
 
 embryogenesis (Cox et al., 1996;
Peifer et al., 1993).
In addition to binding to cadherin, 
 
b
 
-catenin has also
been shown recently to bind to the product of the adeno-
matous polyposis coli (APC)
 
1
 
 tumor suppressor gene. The
APC/
 
b
 
-catenin complex contains 
 
a
 
-catenin but not cad-
herin (Rubinfeld et al., 1993; Su et al., 1993). APC protein
and E-cadherin compete for binding to 
 
b
 
-catenin in tran-
sient expression assays (Hülsken et al., 1994). APC protein
is a 310-kD cytoplasmic protein that is mutated in patients
with the inherited colon cancer syndrome familial ade-
nomatous polyposis. Mutations in APC protein also repre-
sent an early event in a high percentage of sporadic colon
cancers (Groden et al., 1991; Kinzler et al., 1991; Polakis,
1995). The cellular function(s) of APC protein are not
known. In addition to binding catenins, APC protein also
binds to microtubules in vitro and in vivo (Munemitsu
et al., 1994; Polakis, 1995; Smith et al., 1994). In epithelial
cells, APC protein localizes to the ends of microtubule
bundles in actively migrating plasma membrane protru-
sions and to the tips of membranes involved in early cell–
cell contact formation (Näthke et al., 1996). The subcellu-
lar localization of APC protein indicates that it is involved
in cell migration.
To examine domains in 
 
b
 
-catenin that are important for
regulating its subcellular distribution and function(s) in
cadherin and APC protein complexes, we expressed NH
 
2
 
-
and COOH-terminal–deleted 
 
b
 
-catenin in MDCK cells.
Our results demonstrate that deletion of the COOH-ter-
minal domain does not affect the subcellular distribution
of 
 
b
 
-catenin. Deletion of the NH
 
2
 
-terminal domain stabi-
lizes 
 
b
 
-catenin in APC protein and E-cadherin complexes.
NH
 
2
 
-terminal–deleted 
 
b
 
-catenin prominently colocalizes
with APC protein in clusters at the tips of plasma mem-
brane protrusions. MDCK cells expressing NH
 
2
 
-terminal–
deleted 
 
b
 
-catenin are inhibited in early cell–cell contact
formation and compaction when plated at low cell densi-
ties. Both colocalization with APC protein and inhibition
 
of adhesion by NH
 
2
 
-terminal–deleted 
 
b
 
-catenin mutant
proteins are independent of 
 
b
 
-catenin binding to 
 
a
 
-catenin.
 
Materials and Methods
 
Antibodies
 
A rabbit polyclonal antiserum 
 
b
 
-cat.
 
N
 
 was generated in rabbits against
the NH
 
2
 
-terminal 14 amino acids of 
 
b
 
-catenin. Rabbit polyclonal antibod-
ies raised against the COOH-terminal 14 amino acids of 
 
a
 
-catenin and
 
b
 
-catenin (
 
b
 
-cat.
 
C
 
) have been described previously (Hinck et al., 1994
 
b
 
).
A mAb against the COOH-terminal 212 amino acids of 
 
b
 
-catenin (
 
b
 
-cat.
 
C
 
)
was obtained from Transduction Laboratories (Lexington, KY). A mouse
mAb KT3 against a SV-40 large T antigen epitope was kindly provided by
Gernot Walter (University of California, San Diego), and has been de-
scribed previously (MacArthur and Walter, 1984). A polyclonal antibody
against the cytoplasmic domain of E-cadherin has been described previ-
ously (Marrs et al., 1994). Polyclonal antibodies against APC protein were
kindly provided by Paul Polakis (ONYX Pharmaceuticals, Richmond,
VA) and Inke Näthke (Stanford University), and have been described
previously (Näthke et al., 1996; Rubinfeld et al., 1993). Antisera were af-
finity purified with antigen for immunofluorescence as indicated.
 
Plasmid Construction
 
Mouse 
 
b
 
-catenin cDNA (Butz et al., 1992) in pBluescript SKII
 
1
 
 (Strat-
agene, La Jolla, CA) was used to generate deletion mutants (see Fig. 1).
The deduced amino acid sequence is identical to a partial dog 
 
b
 
-catenin
sequence (amino acids 51–311) and identical to the human 
 
b
 
-catenin se-
quence except for one amino acid difference at position 706 (Hülsken et al.,
1994). To detect 
 
b
 
-catenin and 
 
b
 
-catenin mutants immunologically, an oli-
gonucleotide encoding the amino acid sequence KPPTPPPEPET from
SV-40 large T antigen (KT3 epitope tag) was added to the 3
 
9
 
 termini of all
cDNAs (MacArthur and Walter, 1984). Nucleotide sequences of PCR-
derived sequences in constructs shown below were confirmed by direct se-
quencing (PAN Facility, Beckman Center, Stanford University School of
Medicine). The cDNA construct for 
 
D
 
N131 (see below) was found to con-
tain a PCR-introduced point mutation at nucleotide 553 that led to a con-
servative amino acid change of Val
 
175
 
 to Leu
 
175
 
. 
 
D
 
N131
 
 was constructed by PCR using oligonucleotides containing suit-
able restriction sites (5
 
9
 
-SacII/3
 
9
 
-XbaI) for cloning into the pUDH10-3
vector (Gossen and Bujard, 1992). The oligonucleotide defining the start
site of the cDNA (5
 
9
 
-CCATCGATTCTAGACCGCGGCCACCATG-
GCTTTGAAACATGCAGTTGTCAATTTG) contained a Kozak consen-
sus sequence for translation initiation (Kozak, 1989). The oligonucleotide
defining the stop site of the cDNA (5
 
9
 
-CCATCGATTCTAGATTA
 
G-
GTCTCGGGCTCAGGAGGAGGAGTAGGAGGCTT
 
GATATC
 
CA G-
GTCAGTATCAAACCAGGC
 
) codes for 13 additional amino acids in-
cluding the KT3 epitope after the COOH terminus of the mutant protein
(indicated in italics) followed by a stop codon; the underlined sequence is
derived from 
 
b
 
-catenin. In two cloning steps, the BglII and, subsequently,
Eco47III/SpeI fragments of the original cDNA were exchanged for the re-
spective PCR-derived fragments of 
 
D
 
N131 in pUDH10-3. 
 
D
 
N131 was used
to construct a pBluescript KSII
 
1
 
 vector for addition of the KT3 epitope
sequence to the 3
 
9
 
 termini of other cDNAs. The Bsp106I/StuI fragment of
 
D
 
N131 was cloned into pBluescript KSII
 
1
 
-HA (Elferink et al., 1993). The
EcoRV fragment containing the HA tag sequence and the complete
 
D
 
N131 sequence except for the KT3 epitope was subsequently removed.
This resulted in the vector pBluescript KSII
 
1
 
-KT3 in which the sequence
for the KT3 epitope and a stop codon are preceded 5
 
9-upstream by
EcoRV/SmaI/BamHI restriction sites to allow the addition of cDNAs in
all three reading frames.
DNDC was constructed by cloning the blunted BglII fragment of the
original b-catenin cDNA into pBluescript KSII1-KT3/SmaI. The resulting
EcoRI/XbaI fragment, in which the sequence for the KT3 epitope tag is
fused to the sequence of the last repeat in the core region of b-catenin,
was exchanged with the respective EcoRI/XbaI fragment in pUdH10-3/
DN131 to obtain pUDH10-3/DNDC.
DC was constructed by cloning the 59 EcoRI fragment with the start
codon of the original b-catenin cDNA into pUDH10-3. The resulting vec-
tor contained the sequence encoding the NH2-terminal half of b-catenin.
The 39-terminal BglII/XbaI fragment of this b-catenin sequence was re-
placed with the 39 BglII/XbaI fragment of DNDC to obtain the expression
vector pUDH10-3/DC.
1. Abbreviations used in this paper: APC, adenomatous polyposis coli;
Dox, doxycycline; GSK3b, glycogen synthase kinase 3b; RT, room tem-
perature; Tet, tetracycline.Barth et al. Expression of b-Catenin Mutant Proteins in MDCK Cells 695
A vector expressing full-length KT3-tagged b-catenin* was constructed
by exchanging the SpeI/BamHI fragment encoding the COOH-terminal
part of DC in pUDH10-3/DC against the respective fragment encoding the
COOH-terminal part of DN131.
DN90 was constructed by PCR using the oligonucleotide 59-CCATCG-
ATTCTAGACCGCGGCCACCATGGCTCAGAGGGTCCGAGCT for
the 59 terminus of the cDNA and the same oligonucleotide as that used for
the 39 terminus of the cDNA of DN131. The SacII/XbaI PCR fragment
was cloned into pUDH10-3. To replace PCR-derived sequences with orig-
inal cDNA, the SphI/XbaI fragment of DN90 was exchanged with the
SphI/XbaI fragment of full-length KT3-tagged b-catenin.
DN151 was constructed by PCR using the oligonucleotide 59-CCATC-
GATTCTAGACCGCGGCCACCATGGCAATTCCTGAGCTGACA for
the 59 terminus of the cDNA and the same oligonucleotide as that used for
the 39 terminus of the cDNA of DN131. The SacII/XbaI PCR fragment
was cloned into pUDH10-3. To replace PCR-derived sequences with orig-
inal cDNA, the Eco47III/XbaI fragment of DN151 was exchanged with
the Eco47III/XbaI fragment of full-length KT3-tagged b-catenin. PCR-
derived sequences were confirmed by sequencing.
Cell Transfection
MDCK cells (type II) were transfected with pIgR cloned into the pCB6,
which uses the cytomegalovirus promoter to drive pIgR expression and a
G418 drug resistance marker. A well-polarized clone expressing a uni-
formly high level of pIgR was selected and designated B3. The B3 cells
were then cotransfected with plasmid pUHD15-1 (Gossen and Bujard,
1992) coding for the tTa transactivator and pSV2-puro in a ratio of 10:1,
respectively. Transfection was done by the calcium phosphate precipita-
tion method, and cells were plated onto 150-mm dishes. Drug-resistant
clones were selected in the presence of 5 mg/ml puromycin (Sigma Chemi-
cal Co., St. Louis, MO). 180 clones were picked using cloning rings and
then expanded. Each clone was transiently transfected with plasmid
pUHC13-3 consisting of the luciferase gene under control of the tetracy-
cline-regulated promoter in the presence and absence of 1 mg/ml tetracy-
cline, using the lipofectamine reagent (GIBCO BRL, Gaithersburg, MD).
After 48 h, cells were homogenized and tested for luciferase activity.
Clone T23 showed 180-fold more luciferase activity in the absence of tet-
racycline as compared with in its presence. This clone was chosen for fur-
ther studies. T23 cells were cotransfected with vectors for expression of
the tetracycline-repressible transactivator tTA (Gossen and Bujard, 1992)
and a plasmid containing a gene for resistance to puromycin. Parental
MDCK clone T23 was cotransfected with the respective expression vec-
tors for b-catenin mutant proteins (see above; DN90, DN131, DN151,
DNDC,  DC,  b-catenin*) and plasmid pHMR272 carrying a gene for resis-
tance to hygromycin (Gossen and Bujard, 1992) using the lipofectamine
protocol from GIBCO BRL. Clones were selected in 300 mg/ml hygromy-
cin (Boehringer Mannheim Biochemicals, Indianapolis, IN). Low passage
aliquots of drug-resistant MDCK clones were frozen and stored in liquid
nitrogen; clones were passaged in DME medium containing 10% FCS
(Gemini, Calabasas, CA) and 300 mg/ml hygromycin without doxycycline
(Dox) for a maximum of 4–6 wk. In some experiments, expression of
b-catenin mutant proteins was repressed by addition of 1 mg/ml tetracy-
cline (Tet) or 20 ng/ml Dox (Sigma Chemical Co.) to the culture medium.
Cells were cultured 1–3 d without hygromycin before an experiment.
Immunoprecipitation and Immunoblotting
MDCK cells were maintained in DME medium supplemented with 10%
FCS and passaged by mild trypsinization. For preparation of SDS lysates,
MDCK cells were cultured for 4 d with or without 20 ng/ml Dox; cells
were extracted in hot SDS buffer containing 1% SDS, 10 mM Tris-HCl,
pH 7.5, and 2 mM EDTA, and then scraped from the petri dish with a rub-
ber policeman. Samples were boiled for 15 min, and insoluble material
was removed by centrifugation at 12,000 g for 15 min. Protein concentra-
tions were determined using the bicinchoninic acid protein assay reagent
kit (BCA; Pierce Chemical Co., Rockford, Il). Lysates were boiled for 5
min after adding an equal volume of SDS reducing sample buffer (Laemmli,
1970).
For preparation of Triton X-100 lysates, MDCK cells were cultured
with or without 20 ng/ml Dox for 4 d or as indicated, and then extracted
for 15 min at 48C with 1% Triton X-100, 20 mM Tris-HCl, pH 8, 140 mM
NaCl, 1.5 mM MgCl2, 1 mM EGTA, 10% glycerol (vol/vol), 10 mg/ml
DNase and RNase, 1 mM sodium vanadate, 50 mM NaF, and a protease
inhibitor mix (1 mM Pefabloc, 1 mM benzamidine, and 10 mg/ml each of
aprotinin, pepstatin, and leupeptin); DNase, RNase, Pefabloc, pepstatin,
and leupeptin were purchased from Boehringer Mannheim Biochemicals,
and all other reagents were from Sigma Chemical Co. After extraction,
cells were scraped from the petri dish with a rubber policeman. Insoluble
material was removed by centrifugation at 12,000 g for 30 min. Protein
concentrations were determined using the BCA protein assay reagent kit
(Pierce Chemical Co.). Portions of lysates were boiled for 5 min after add-
ing an equal volume of SDS reducing sample buffer. Other portions of ly-
sates were precleared by incubation with 5 ml of nonimmune rabbit serum
and 100 ml Pansorbin (Calbiochem-Novabiochem Corp., La Jolla, CA) for
1 h at 48C. After removing the Pansorbin by centrifugation, lysates were
incubated for 2–3 h at 48C with either 30 ml protein A–Sepharose (Phar-
macia Fine Chemicals, Piscataway, NJ) coupled to E-cadherin or b-catenin
antibody, or 60 ml protein A–Sepharose coupled to a-catenin or APC pro-
tein antibody. Immunoprecipitates were washed once with wash buffer
(0.5% NP-40, 20 mM Tris-HCl, pH 8, 150 mM NaCl), once with wash
buffer containing 1 M LiCl, and once with wash buffer. Immunoprecipi-
tates were boiled in 30 or 60 ml SDS reducing sample buffer.
Lysates and immunoprecipitates were separated by SDS-PAGE in
7.5% polyacrylamide gels (Laemmli, 1970). Gels were transferred to ni-
trocellulose membranes with a pore size of 0.45 mm (Schleicher & Schuell
Inc., Keene, NH) in a buffer containing 25 mM Tris-HCl, pH 7.4, 50 mM
glycine, and 20% methanol. Membranes were stained with Ponceau S to
check for protein transfer, and then destained in 20 mM Tris-HCl, pH 7.4,
0.5% Tween-20, 140 mM NaCl (TTS). Membranes were blocked over-
night at 48C in TTS with 5% powdered milk. Primary antibodies were in-
cubated with membranes for 2 h at room temperature (RT) in TTS with
5% powdered milk. Membranes were washed four times for 10 min each
with TTS, and then incubated with the appropriate secondary antibodies
coupled to HRP (Amersham Corp., Arlington Heights, IL) in TTS, 5%
powdered milk, and 5% serum from the animal species that was used to
generate the secondary antibody. Membranes were washed for at least 2 h
with six changes of TTS, and antibody reactivity was visualized with en-
hanced chemiluminescence reagent (Amersham Corp.). Bands on ECL-
exposed X-OMAT AR film (Eastman Kodak Co., Rochester, NY) were
analyzed with a GS 300 transmittance/reflectance scanning densitometer
(Hoefer Scientific Instruments, San Francisco, CA), or scanned with a
ScanJet IIc (Hewlett-Packard Co., Palo Alto, CA) and analyzed with NIH
Image. All reagents were from Sigma Chemical Co. unless indicated oth-
erwise.
Immunofluorescence and Phase-Contrast Microscopy
For immunofluorescence, MDCK cells were cultured and plated on 35-
mm tissue-culture dishes with collagen-coated coverslips in DME medium
supplemented with 10% FCS with or without Tet as indicated. For immu-
nofluorescence of low density cultures, 1 3 105 cells were plated and fixed
after 24 h. Part of a culture of clone DN131-D was preincubated for 24 h
in 1 mg/ml Tet before plating onto coverslips and was kept in medium
containing Tet until fixation. Cells were washed once in Dulbecco’s PBS
(0.9 mM CaCl2, 2.7 mM KCl, 1.5 mM KH2PO4, 0.5 mM MgCl2, 137 mM
NaCl, and 8.1 mM NaHPO4) and fixed for 20 at RT in 2% formaldehyde
in Dulbecco’s PBS. Cells were washed four times for 5 min each in Dul-
becco’s PBS with 50 mM NH4Cl, blocked, and permeabilized for 20 min in
Dulbecco’s PBS with 50 mM NH4Cl, 1% BSA, 2% goat serum, and 0.05%
Saponin (blocking buffer). Cells were incubated 1 h at RT with primary
antibody in blocking buffer and washed four times for 5 min each in Dul-
becco’s PBS with 50 mM NH4Cl. Cells were incubated 1 h at RT with fluo-
rescein- or rhodamine-conjugated goat secondary antibodies (Jackson Im-
munoResearch Laboratories, West Grove, PA) in blocking buffer, and
then washed four times for 5 min each in Dulbecco’s PBS with 50 mM
NH4Cl. Antibodies were used in the following dilutions: affinity-purified
E-cadherin antiserum 1:50; affinity-purified a-catenin antiserum 1:50;
mouse mAb KT3 1:50; b-cat.N antiserum 1:200; and secondary antibodies
1:200. For KT3/APC protein double immunofluorescence, 5 3 105 cells
were plated onto collagen-coated coverslips in 35-mm tissue-culture
dishes and fixed after 48 h. Cells were washed once in Dulbecco’s PBS,
fixed for 5 min at 2208C in precooled methanol, washed four times in
Dulbecco’s PBS, and blocked in Dulbecco’s PBS with 1% BSA and 2%
goat serum (blocking buffer). Cells were incubated for 1 h at RT with pri-
mary antibody in blocking buffer, washed four times for 5 min each in
Dulbecco’s PBS, incubated 1 h at RT with fluorescein- or rhodamine-con-
jugated goat secondary antibodies (Jackson ImmunoResearch Laborato-
ries) in blocking buffer, and washed four times for 5 min each in Dul-
becco’s PBS. Antibodies were used in the following dilutions: mouse mAbThe Journal of Cell Biology, Volume 136, 1997 696
KT3 1:50; and APC protein antiserum 1:200. Cells were mounted in a mix-
ture of 16.7% Mowiol (Calbiochem-Novabiochem Corp.), 33% glycerol,
and 0.1% phenylenediamine in Dulbecco’s PBS without CaCl2 and MgCl2
and viewed with an Axiophot inverted fluorescence microscope (Carl
Zeiss Inc., Thornwood, NY) using a 363 oil immersion objective. For
phase-contrast microscopy of low density cultures, each clone was split
and cultured for 3 d with or without 20 ng/ml Dox. 5 3 105 cells were
plated onto 100-mm tissue-culture dishes in medium with or without 20
ng/ml Dox, and photomicrographs of the cultures were taken 24 and 48 h
after plating with an Axiovert 10 phase-contrast microscope (Carl Zeiss
Inc.).
Results
Expression of b-Catenin Mutant Proteins
in MDCK Cells
Mutant b-catenin proteins lacking NH2-terminal 90 (DN90),
131 (DN131), 151 (DN151) amino acids, or COOH-terminal
86 amino acids (DC), and full-length b-catenin (b-catenin*)
were expressed in MDCK cells (Fig. 1). The sequence for
the SV-40 large T antigen epitope recognized by the mAb
KT3 (MacArthur and Walter, 1984) was added to the 39
termini of all cDNA constructs to distinguish protein
products from endogenous b-catenin. All constructs were
expressed under the control of the Tet-repressible transac-
tivator; in the presence of either Tet or Dox, expression of
exogenous protein is completely repressed (Gossen and
Bujard, 1992).
MDCK clones cultured for 4 d without or with doxycy-
cline (2/1 Dox) were analyzed for expression of mutant
b-catenins (Fig. 2). Mutant b-catenins (Fig. 2, a–c; marked
with stars in b-cat.C, b-cat.N, and KT3 blots) were detected
in protein extracts from clones cultured without Dox,
but not in extracts from clones cultured with Dox. 15–20
clones were analyzed for every construct. Mutant b-catenin
levels in clones expressing DN90, DN131, or DN151 b-cate-
nin were on average higher than that in clones expressing
b-catenin* and DC b-catenin. However, the level of DN151
in clone DN151-D was similar to b-catenin* in clone b-cate-
nin*–10 (Fig. 2 c; KT3 blot). In the clones shown in Fig. 2,
the ratios of DN90, DN131, DN151, or DC b-catenin to
MDCK endogenous b-catenin were 5:1, 1:1, 0.5:1, and 1:1,
respectively (Fig. 2 a, lanes 7, 9, and 11; Fig. 2 b, lane 5).
Expression of E-cadherin leads to an increase in the cel-
lular levels of catenins (Herrenknecht et al., 1991; Weißig,
1993). Therefore, we analyzed whether expression of b-cate-
nin mutant proteins affected levels of endogenous b-cate-
nin, E-cadherin, or a-catenin by comparing their amounts
in lysates from clones cultured without or with Dox. Ex-
Figure 1. Schematic representation of KT3-tagged full-size and
mutant b-catenin proteins. NH2- and COOH-terminal domains
and the 13 internal armadillo-like repeats of b-catenin are indi-
cated. A stretch of unrepeated amino acids between repeat 10
and 11 (empty box) is shown. The binding sites for a-catenin,
E-cadherin, APC, and the epitopes for rabbit b-catenin antisera
b-cat.N, b-cat.C, and mouse mAb KT3 are indicated. The epitope
for antiserum b-cat.N is deleted in DN90, DN131, and DN151, and
these mutant proteins are not detected by b-cat.N. A mouse mAb
raised against the 212 COOH-terminal amino acids of b-catenin
was used instead of antiserum b-cat.C, and both b-cat.C antibodies
do not detect DC. The following amino acids are deleted in the
mutants: DC, 696–781; DN90, 1–90; DN131, 1–131; DN151, 1–151.
Figure 2. Dox-repressible expression of b-catenin mutant pro-
teins in MDCK cells. MDCK clones were cultured for 4 d without
or with Dox (2/1 Dox) and extracted with 1% SDS. 15-mg pro-
tein lysates were subjected to SDS-PAGE and immunoblotted
with different antibodies (see Fig. 1). b-catenin mutant proteins
(stars in a–c) were expressed only in cultures without Dox; en-
dogenous b-catenin was expressed in all cultures (a and b). Ex-
pression levels of exogenous full-length b-catenin*, DN90, DN131,
and DN151 were compared with that of endogenous b-catenin by
immunoblotting with mAb b-cat.C (a). Exogenous b-catenin* and
DC were compared with endogenous b-catenin by immunoblot-
ting with b-cat.N (b). The expression levels of mutant b-catenin
proteins in different clones were compared by immunoblotting
with the tag antibody KT3 (c). The b-cat.C blot was reblotted with
E-cadherin antiserum (d). The KT3 blot was reblotted with a-cat-
enin antiserum (e). Molecular mass standards are indicated in kD.Barth et al. Expression of b-Catenin Mutant Proteins in MDCK Cells 697
pression of DN90, DN131, or DN151 did not significantly
affect the level of endogenous b-catenin (Fig. 2, a and b,
compare lanes 7 to 8, 9 to 10, and 11 to 12, respectively).
Expression of DC b-catenin resulted in a small but repro-
ducible decrease in amount of endogenous b-catenin (Fig.
2, a and b, lanes 5 and 6). Although full-length exogenous
b-catenin* and endogenous b-catenin were not always
well separated by SDS-PAGE because of similarity in
their electrophoretic mobilities, a decrease of endogenous
b-catenin in response to the expression of b-catenin* was
detectable in some of these clones (Fig. 2 a, lanes 3 and 4).
The amount of E-cadherin was slightly higher in clones
expressing DN90 b-catenin (DN90-A) and DN131 b-cate-
nin (DN131-D) compared with levels in b-catenin–10* and
DC clones (Fig. 2 d). Differences in E-cadherin levels may
be the result of clonal variation since the amount of E-cad-
herin in a particular clone was not significantly affected af-
ter repression of mutant b-catenin expression by addition
of Dox (Fig. 2 d; compare lanes 7 to 8, 9 to 10, and 11 to 12,
respectively). Expression of mutant b-catenins did not
have a significant effect on amounts of a-catenin in all
clones except DN131-D in which the a-catenin level was
slightly decreased when cells were cultured without Dox
(Fig. 2 e, lanes 9 and 10).
Mutant b-Catenin Proteins Compete with Endogenous 
b-Catenin for Binding to E-Cadherin and a-Catenin
Binding of b-catenin mutants to E-cadherin and a-catenin
was analyzed by coimmunoprecipitation of protein com-
plexes (Fig. 3). The binding site for E-cadherin in b-catenin
is located within the armadillo repeat domain of b-catenin
(Aberle et al., 1994; Hülsken et al., 1994) and was retained
in all mutant proteins. Accordingly, all b-catenin mutant pro-
teins were coimmunoprecipitated by E-cadherin antibody
(Fig. 3 a; KT3 blot). Binding of DN90 and DN131 b-catenin
to E-cadherin resulted in a reduction in amount of endog-
enous  b-catenin complexed with E-cadherin compared
with the amount of endogenous b-catenin in similar com-
plexes isolated from the same clones cultured with Dox
(Fig. 3 b; b-cat.C blot; compare lanes 5 and 6, and 7 and 8,
respectively). The binding site for a-catenin is located be-
tween amino acids 120 and 151 in b-catenin (Aberle et al.,
1994, 1996) and was incomplete or missing in DN131 and
DN151 b-catenin. Accordingly, DN131 and DN151 b-cate-
nin were not coimmunoprecipitated by a-catenin antibody
(Fig. 3 c; KT3 blot). Binding of DN90 and DC b-catenin to
a-catenin resulted in a reduction in amount of endogenous
b-catenin bound to a-catenin compared with endogenous
b-catenin in complexes with a-catenin that were isolated
from the same clones cultured in the presence of Dox (Fig.
3 d; b-cat.C blot; compare lanes 5 and 6, and 11 and 12, re-
spectively). These results confirm that DN90 and DC b-cat-
enin retained both E-cadherin and a-catenin binding sites,
and that DN131 and DN151 b-catenin retained the E-cad-
herin, but not a-catenin, binding site; all mutant b-catenin
proteins competed with endogenous b-catenin for these
binding partners.
NH2-terminal–deleted Mutant Proteins of b-Catenin 
Are Enriched in APC Protein Complexes
Binding of mutant b-catenins to APC protein was also an-
alyzed by coimmunoprecipitation. All mutant b-catenins
were coimmunoprecipitated by APC protein antibody
(Fig. 4). However, DN90, DN131, and DN151 b-catenin were
significantly enriched in APC protein immunoprecipitates
compared with endogenous b-catenin, DC, or exogenous
b-catenin*. Three times more DN90, DN131, or DN151 was
coimmunoprecipitated with APC protein than endoge-
nous  b-catenin (Fig. 4 c). Note that total amounts of mu-
tant b-catenin in lysates used for immunoprecipitation were
either similar to, or less than that of, endogenous b-cate-
nin (Fig. 4 a); the ratios of DN90, DN131, or DN151 b-cate-
nin to endogenous b-catenin in Triton X-100 lysates were
1.6:1, 1.3:1, and 0.1:1, respectively. Very little DC b-catenin
was detected in APC protein complexes, although as much
DC as DN151 b-catenin was present in the Triton X-100
lysates of each clone (compare Fig. 4 b and 4 d; KT3 blots).
These data indicate that, compared with endogenous
b-catenin, NH2-terminal–deleted b-catenins bind prefer-
entially to APC protein. In addition, the amount of DN151
b-catenin that is complexed with APC protein is very simi-
lar to that of DN90 and DN131 b-catenin, even though
Figure 3. b-catenin mutant proteins compete with endogenous
b-catenin for binding to E-cadherin and a-catenin. MDCK clones
were cultured 4 d without or with Dox (2/1) and extracted with
1% Triton X-100 lysis buffer. Protein lysates were split: 400-mg
lysates were immunoprecipitated with E-cadherin antiserum to
analyze binding of mutant b-catenin proteins to E-cadherin (a and
b). 400 mg protein lysates were immunoprecipitated with a-catenin
antiserum to analyze binding of mutant b-catenin proteins to
a-catenin (c and d). Equivalent fractions of the immunoprecipi-
tates were subjected to SDS-PAGE and blotted with mAbs KT3
(a and c) or b-cat.C (b and d). b-catenin mutant proteins are indi-
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there is much less DN151 b-catenin in clone DN151-D.
Therefore, we suspect that binding of NH2-terminal–deleted
b-catenin to APC protein approaches a maximum.
To further explore the degree of enrichment of mutant
b-catenin in APC protein complexes, amounts of b-cate-
nin* and DN131 b-catenin bound to APC protein were
compared in two different clones (b-cat.*-7 and DN131-7;
Fig. 4 e). Portions of Triton X-100 lysates of these clones were
used to immunoprecipitate both full-length and deleted
b-catenin with b-cat.C antiserum, or to coimmunoprecipi-
tate APC protein complexes. In b-cat.C immunoprecipi-
tates, the ratios of endogenous b-catenin to b-catenin* in
the b-catenin*-7 clone, and those of endogenous b-catenin
to DN131 in the DN131-7 clone, were z1:1. In APC pro-
tein immunoprecipitates, the ratio of endogenous b-cate-
nin to b-catenin* was also z1:1, but, in contrast, the ratio
of endogenous b-catenin to DN131 b-catenin was z1:3.
DN131  b-catenin was considerably more abundant in APC
protein immunoprecipitates than either endogenous b-cate-
nin or exogenous full-length b-catenin* (Fig. 4 e).
NH2-terminal Deletions Result in Increased b-Catenin 
Stability in APC Protein and E-Cadherin Complexes
Enrichment of DN90, DN131,and DN151 b-catenins bound
to APC protein could be caused by increased stability of
these b-catenins in the complex. To test this hypothesis,
expression of b-catenin mutant proteins was repressed by
addition of Dox to cultures for 0, 6, 12,or 18 h. Amounts of
mutant  b-catenin remaining in Triton X-100 lysates of
these cells, and in E-cadherin and APC protein complexes
isolated from those lysates, were analyzed by immunopre-
cipitation and/or Western blotting (Fig. 5).
A significant increase in the relative stabilities of NH2-
Figure 4. DN90, DN131, and DN151 are enriched in APC protein
complexes. Aliquots of the same Triton X-100 lysates as de-
scribed in Fig. 3 were either subjected to SDS-PAGE or used for
immunoprecipitation with APC antiserum (a–d). 9-mg protein ly-
sates were subjected to SDS-PAGE and immunoblotted with the
indicated mAbs to compare the ratio of b-catenin mutant pro-
teins to endogenous b-catenin (a), and to each other (b). 1,500-mg
protein lysates were immunoprecipitated with APC antiserum.
Equivalent fractions of the immunoprecipitates were subjected to
SDS-PAGE and blotted with the indicated mAbs to analyze
binding of mutant b-catenin proteins to APC (c–d). b-catenin
mutant proteins are indicated (stars). A longer exposure of the
blot in (d) is shown for lanes 7 and 8. Triton X-100 lysates were
prepared from clones b-catenin*–7 and DN131-7, and aliquots of
the lysates were immunoprecipitated with antiserum b-cat.C or
APC antiserum (e). Immunoprecipitates were subjected to SDS-
PAGE and blotted with antiserum b-cat.C to analyze the ratio of
exogenous b-catenin* and DN131 to endogenous b-catenin. b-cat-
enin mutant proteins are indicated (stars).
Figure 5. Increased stability of DN90, DN131, and DN151 in the
E-cadherin– and APC protein–bound pools. MDCK clones were
cultured 0, 6, 12, or 18 h with Dox and extracted with 1% Triton
X-100 lysis buffer. Protein lysates were split: 1,500-mg protein ly-
sates were immunoprecipitated with APC antiserum (first col-
umn), and 500-mg lysates were immunoprecipitated with E-cad-
herin antiserum (second column). Equivalent fractions of the
immunoprecipitates and 50-mg (b-cat.*-10,-7, DC-9) or 25-mg
(DN90-A, DN131-D, DN151-D) protein lysates (third column)
were subjected to SDS-PAGE and immunoblotted with mAb
KT3. For b-catenin*–10, –7, and DC-9 blots, three times more of
the APC immunoprecipitations were used than for the DN90-A,
DN131-D, and DN151-D blots, and the blots were exposed longer.Barth et al. Expression of b-Catenin Mutant Proteins in MDCK Cells 699
terminal–deleted  b-catenins compared with full-length
b-catenin* or DC b-catenin was detected in E-cadherin
and APC protein complexes from lysates. This difference
in stability was most pronounced in the APC protein–
bound pools. Very little or no full-length b-catenin* or DC
b-catenin were detected in the APC protein complex after
only 6 h of treatment with Dox. In contrast, there was little
or no decrease in amounts of DN90, DN131, or DN151 b-cate-
nin in the APC protein complex after 18 h of treatment
with Dox. In the E-cadherin–bound pools of lysates, 10–
12% of the original amount of full-length b-catenin* and
DC b-catenin was detected after 12 h of treatment with Dox.
In contrast, amounts of DN90, DN131, or DN151 b-catenin
bound to E-cadherin were not or little reduced after 18 h
of treatment with Dox.
In the total Triton X-100 lysates, the amounts of all mu-
tant b-catenin proteins were reduced after 12 to 18 h of
treatment with Dox. The percentage of remaining mutant
protein after 12 h of treatment with Dox is 17% and 18%
of b-catenin* in clones b-catenin*–7 and b-catenin*–10,
respectively; 18% of DC b-catenin; 44% of DN90 b-catenin;
32% of DN131 b-catenin; and 26% of DN151 b-catenin.
The close similarity in the decrease in amounts of b-cate-
nin* in two independent clones indicates that the rate and
efficiency of Dox repression of gene expression were simi-
lar in different MDCK clones. Assuming that this is also
the case in other clones, the half-life of DC is similar to
that of full-length b-catenin*, whereas DN90, DN131, and
DN151 b-catenin are slightly more stable than full-length
b-catenin*. The mutant b-catenin proteins in the total TX-
100 lysates represent the sum of the E-cadherin– and
APC-bound, and unbound pools. Although DN90, DN131,
or  DN151  b-catenin was very stable in E-cadherin and
APC protein complexes, their overall stability in the ly-
sates was not very different from that of full-length b-cate-
nin* and DC b-catenin. This indicates that pools of DN90,
DN131, and DN151 b-catenin that are not bound to either
E-cadherin or APC protein turn over at a rate similar to
that of full-length b-catenin* and DC b-catenin.
The high stability of the NH2-terminal–deleted b-cate-
nins in the APC protein complexes correlated with the en-
richment of these mutant proteins in the APC protein
complexes compared with endogenous b-catenin in the
same cells (Fig. 4). Surprisingly, we could not detect an
enrichment of NH2-terminal–deleted b-catenins in the
E-cadherin pool when compared with endogenous b-cate-
nin in the same cells (see Fig. 3 c), even though NH2-termi-
nal–deleted b-catenins were more stable than full-length
exogenous b-catenin* in the E-cadherin complexes of dif-
ferent clones (Fig. 5). We note that most of the E-cadherin
in MDCK cells is normally bound to endogenous b-cate-
nin in a 1:1 molar ratio (Hinck et al., 1994a). In contrast,
most of the APC protein appears to be free of endogenous
b-catenin (Näthke et al., 1996). Therefore, NH2-terminal–
deleted b-catenins must compete with endogenous b-cate-
nin to bind to E-cadherin, but they may be enriched in the
APC protein pool by binding unoccupied sites and re-
maining stabilized in these complexes. This may explain
the difference in the ratios of the mutant proteins to en-
dogenous  b-catenin when comparing the E-cadherin–
bound or APC-bound pools in the same cultures (Figs. 3
and 4).
NH2-terminal–deleted b-Catenin Prominently
Localizes in Clusters with APC Protein at Tips of 
Plasma Membrane Protrusions
Our immunoprecipitation studies show that NH2-termi-
nal–deleted  b-catenin proteins form stable complexes with
E-cadherin and APC protein. We examined the subcellu-
lar distribution of mutant b-catenins by immunofluores-
cence microscopy. Mutant b-catenins were epitope tagged
and can be distinguished from endogenous b-catenin with
the monoclonal anti-tag antibody KT3. We examined two
types of cell cultures: low density cultures in which small
groups of cells had initiated cell–cell contacts (Fig. 6), and
high density cultures in which mature cell–cell contacts
had been established (Fig. 7).
DN90, DN131, and DN151 b-catenins prominently local-
ized to clusters at the outer boundary of cell–cell contacts
and at the tips of plasma membrane protrusions (Fig. 6,
a–d, arrowheads). Neither E-cadherin, endogenous b-cate-
nin, nor a-catenin colocalize with the NH2-terminal–
deleted  b-catenins in theses clusters (Fig. 6, a9–d9, arrow-
heads). This distinctive subcellular distribution is very
similar to that of APC protein in MDCK cells (Näthke et al.,
1996). Therefore, we examined colocalization of the mu-
tant b-catenin proteins with APC protein in these clusters
(Fig. 7). DN90, DN131, and DN151 b-catenins colocalized
precisely with APC protein in almost all clusters at the tips
of plasma membrane protrusions; incidences of APC pro-
tein clusters without DN90, DN131, or DN151 b-catenins
were very rare (Fig. 7, middle panels). However, full-
length  b-catenin* and DC b-catenin localized to intercellu-
lar contacts, and there was little overlap in distributions
between these proteins and APC protein (Fig. 7, top and
bottom panel).
In low density cultures, DN90, DN131, and DN151 b-cate-
nins were poorly localized at intercellular contacts, com-
pared with strong staining for E-cadherin and a-catenin at
the same sites (Fig. 6). In these cell–cell contact areas,
NH2-terminal–deleted b-catenin mutant proteins colocal-
ized with E-cadherin, endogenous b-catenin, and a-cate-
nin (Fig. 6, a–d, and a9–d9, arrows). Localization of DN90,
DN151, and DN131 b-catenins to intercellular contacts was
much more prominent in high density cultures (Fig. 7; KT3
immunofluorescence). The distribution of b-catenin* and
DC was identical to that of endogenous b-catenin (data
not shown).
Note that some nuclear staining was detected with the
KT3 antibody (see Fig. 6, a–d), but that the staining per-
sisted in the absence of mutant protein expression (see
Fig. 6 e), indicating that nuclear staining was not specific to
mutant b-catenin in these cells.
Distinct Differences in Morphologies of Cells 
Expressing NH2-terminal–deleted b-Catenin Compared 
With Cells Expressing b-Catenin* and DC b-Catenin
We examined the morphology and colony formation of
cells expressing different mutant b-catenins. In low density
cultures, the morphology of cells expressing DN90, DN131,
or DN151 b-catenins was distinctly different from that of the
same cells treated with Dox (i.e., without mutant b-catenin
expression; Fig. 8), parental MDCK cells, and cells ex-
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Cells treated with Dox, parental MDCK cells, and cells ex-
pressing  b-catenin* or DC b-catenin produced compact
cell colonies; note that cells at the edges of colonies rarely
extended membrane protrusions onto the surrounding
cell-free surface. In addition, we found very few individual
cells that were not associated with colonies in these cul-
tures. Neither addition of Dox to the cultures nor addition
of the KT3 tag to full-length b-catenin affected the mor-
phology of either parental MDCK cells (Fig. 8, top panel)
or b-catenin*–expressing cells (data not shown), respec-
tively. In contrast, the surface area of cells expressing
DN90,  DN131, or DN151 b-catenins (i.e., in the absence of
Dox) was greater than that of control cells, indicating that
the former were poorly compacted. Cells loosely associ-
ated in colonies also had many membrane extensions pro-
jecting onto the surrounding cell-free surface. In addition,
many individual cells were not associated directly with col-
onies and were dispersed throughout the culture; in gen-
eral, these cells have a more fibroblastic morphology than
control cells (Fig. 8). Repression of DN90, DN131, or
DN151  b-catenin expression by treatment with Dox reverted
the morphology of cells to compacted colonies typical of pa-
rental MDCK cells (Fig. 8, top panels; see also Fig. 6, e and e9).
At higher cell densities in which there was less free sur-
face available for cell migration, differences in morpholo-
gies of cells expressing DN90, DN131, or DN151 b-catenins
and control cells were less evident. Cells expressing DN90,
DN131, or DN151 b-catenins established compact colonies
and, eventually, formed complete monolayers similar to
those of control cells (see Fig. 7).
Discussion
b-Catenin binds independently to E-cadherin and APC
protein, and one function of these interactions is to link
E-cadherin to the actin cytoskeleton via a-catenin (Aberle
et al., 1994; Hülsken et al., 1994; Jou et al., 1995; Rimm
et al., 1995). In the case of E-cadherin, this hierarchy of
protein interactions is important for regulating E-cadherin
function in establishing cell–cell adhesion (Ozawa and
Kemler, 1992). The role of catenin binding in APC protein
function(s) is not known, but it has been suggested that
APC protein may regulate cellular b-catenin levels (Mun-
emitsu et al., 1995; Papkoff et al., 1996). In this study, we
examined interactions of b-catenin mutant proteins with
E-cadherin, a-catenin, and APC protein, and investigated
their subcellular distributions and effects on the morphol-
ogy of MDCK epithelial cells. Our results provide novel
insights into the roles of b-catenin in regulating E-cad-
herin and/or APC protein functions: (a) NH2-terminal de-
letion of b-catenin results in stabilization of b-catenin in
APC protein complexes; (b) full-length b-catenin poorly
colocalizes with APC protein, but NH2-terminal–deleted
b-catenin strongly colocalizes with APC protein in clusters
at the tips of membrane protrusions; (c) expression of
NH2-terminal–deleted b-catenin affects cell morphology
and intercellular adhesion; (d) the effects on cell morphol-
ogy are independent of b-catenin binding to a-catenin;
and (e) alterations in b-catenin binding to APC protein,
the subcellular location of mutant b-catenin/APC protein
complexes, and the resulting changes in cell morphology
imply that APC protein is involved in cell migration and that
b-catenin binding to APC protein regulates this function.
Regulation of b-Catenin Distribution between Different 
Cellular Pools
Epitope-tagged DN90, DN131, and DN151 and DC b-catenin
were expressed in MDCK cells using a Dox/Tet-repress-
ible expression system. As an additional control, epitope-
tagged full-length b-catenin (b-catenin*) was expressed in
MDCK cells. Expression of b-catenin mutant proteins had
no significant effect on cellular levels of E-cadherin and
a-catenin. However, a small but reproducible reduction in
the amount of endogenous b-catenin was observed in cells
expressing full-length b-catenin* or DC b-catenin (Fig. 2).
All b-catenin mutant proteins competed with MDCK
endogenous b-catenin for binding to E-cadherin (Figs. 3
and 4). Exogenous full-length b-catenin*, DN90, and DC
b-catenin competed with MDCK endogenous b-catenin for
binding to a-catenin, whereas DN131 and DN151 b-catenin
were not associated with a-catenin (Fig. 3).
Comparison of the amounts of NH2-terminal–deleted and
endogenous b-catenin coimmunoprecipitated in a complex
with APC protein revealed that mutant b-catenins were
specifically enriched. By comparison, endogenous b-cate-
nin was not enriched in the same coimmunoprecipitates
(Fig. 4). The enrichment of mutant b-catenin in the APC
protein complex was independent of binding of mutant
b-catenin to a-catenin. Our data suggest that the NH2-ter-
minal domain of b-catenin is important for regulating its
stability in the APC protein complex (Fig. 5). Similar ob-
servations have been reported recently by Munemitsu et
al. (1996). APC protein stimulates b-catenin degradation
in some cell lines (Munemitsu et al., 1995). Although the
mechanism regulating the dynamics of b-catenin interac-
tions with APC protein remains to be elucidated, phos-
phorylation of APC protein (Rubinfeld et al., 1996) and/or
b-catenin by glycogen synthase kinase 3b (GSK3b) may
be important. GSK3b associates with the APC protein/b-
catenin complex in some cell lines (Rubinfeld et al., 1996).
The NH2 terminus of b-catenin contains a GSK3b phos-
phorylation site, and we are currently investigating the
role of this site for b-catenin stability in the APC complex.
Interestingly, b-catenin mutants lacking this site are more
stable than wild-type b-catenin in Xenopus embryos (Yost
Figure 6. DN151, DN131, and DN90 localize to clusters near the plasma membrane in extending membranes of MDCK cells. MDCK clones
were double stained with mAb KT3 against the epitope tag in b-catenin mutant proteins (a–e) and antiserum against E-cadherin (a9),
antiserum b-cat.N against endogenous b-catenin (b9), and antiserum against a-catenin (c9–e9). Areas with DN151, DN131, and DN90 clus-
ters are indicated by arrowheads (a–d). These clusters are not detected with E-cadherin, endogenous b-catenin, or a-catenin antisera
(a9–d9, arrowheads). DN131 expression was repressed in DN131-D by 48 h incubation with Tet before fixation (e). (Arrows) Areas of in-
tercellular contact that are stained by antisera to E-cadherin (a9), endogenous b-catenin (b9), a-catenin (c9–e9), and sometimes weakly by
mAb KT3 (a–d). Bar, 10 mm.The Journal of Cell Biology, Volume 136, 1997 702
et al., 1996), indicating that the phosphorylation state of
b-catenin regulates b-catenin turnover. Our data also
show that NH2-terminal–deleted b-catenin is more stable
in E-cadherin complexes than full-length and DC b-cate-
nin (Fig. 5). Regulation of b-catenin stability in E-cad-
herin complexes may be determined by mechanism(s) sim-
ilar to those in the APC protein complexes.
NH2-terminal–deleted b-Catenin Mutant Proteins 
Colocalize with APC Protein in Clusters at Tips of 
Plasma Membrane Protrusions
Recent studies by Näthke et al (1996) demonstrated that
APC protein localizes to clusters of puncta at the tip of
actively migrating cellular protrusions and at the outer
Figure 7. DN90, DN131, and DN151 colocalize with APC protein in MDCK cells. MDCK clones were double stained with mAb KT3
against the epitope tag in b-catenin mutant proteins and antiserum against APC protein. Full-length b-catenin* and DC localize to the
lateral membranes of cells and show little overlap with APC protein clusters (top and bottom panel). DN90, DN131, and DN151 localize
to lateral membranes of cells and colocalize with APC protein in clusters (middle panels). Bar, 10 mm.Barth et al. Expression of b-Catenin Mutant Proteins in MDCK Cells 703
boundaries of newly formed cell–cell contacts. This distri-
bution indicates that one function of APC protein is to
regulate specific types of cell migration. Whereas endoge-
nous b-catenin is seldom detected in the APC protein clus-
ters,  DN90,  DN131, and DN151 b-catenin prominently
colocalized with APC protein in these clusters (Fig. 7). This
colocalization was independent of mutant b-catenin bind-
ing to a-catenin, since neither DN131 nor DN151 b-catenin
bound a-catenin. Surprisingly, localization of DN90 b-cate-
nin to APC protein clusters was not accompanied by strong
colocalization of a-catenin, even though this mutant b-cate-
nin retained an a-catenin binding site and formed com-
plexes with a-catenin (Fig. 6, c and c9).
Preliminary studies show that localization of DN90,
Figure 8. Effect of DN90, DN131, and DN151 expression on colony formation in low density MDCK cultures. Cultures of MDCK clones
were untreated or pretreated 3 d with Dox and plated at low density without (2) or with (1) Dox. Cell morphology was analyzed 24 and
48 h after plating. Expression of DN90, DN131, and DN151 delayed formation of tight round colonies in low density cultures (first and
third columns). This effect could be reversed by repression of expression of DN90, DN131, and DN151 with Dox (second and fourth col-
umns). Dox itself had no effect on the morphology of the parental cells (top panel). Bar, 40 mm.The Journal of Cell Biology, Volume 136, 1997 704
DN131, and DN151 b-catenin in APC protein clusters is
disrupted by nocodazole but not by cytochalasin D (data
not shown), suggesting that linkage of the APC protein
complex to microtubules, rather than to actin filaments,
may be more important for APC protein localization and,
perhaps, function (see also Näthke et al., 1996).
Expression of NH2-terminal–deleted b-Catenin Inhibits 
Colony Formation in Low Density Cultures
We examined the effects of mutant b-catenin expression
on MDCK cell morphology. Cultures of cells were initi-
ated from single cells that normally migrate, form contacts
with other cells, and, by 24 h, establish small colonies.
Three general differences in morphology were detected in
cells expressing DN90, DN131, or DN151 b-catenin com-
pared with control cells. At low density, cells were dis-
persed, more fibroblastic in morphology, and less efficient
at forming colonies. At high density, cells formed mono-
layers similar in morphology to those of controls (data not
shown). Differences in morphology of cells expressing mu-
tant b-catenin compared with control cells may be due to a
combination of decreased cell–cell adhesion and either de-
creased movement resulting in a lower probability of cells
contacting each other, or increased migration resulting in
dispersion of cells.
Poor colony formation and decreased compaction of cells
within colonies may be caused by interference of E-cad-
herin function by b-catenin mutants. E-cadherin plays a
key role in the initial formation of cell–cell contacts in
MDCK cells (Gumbiner et al., 1988; McNeill et al., 1993),
and linkage of E-cadherin to the cortical actin cytoskele-
ton via b-catenin and a-catenin is essential for cell–cell ad-
hesion (Hirano et al., 1987; Nagafuchi and Takeichi, 1988;
Ozawa et al., 1990). DN131 and DN151 b-catenin may dis-
rupt E-cadherin function because these mutant proteins
cannot bind a-catenin and, hence, the actin cytoskeleton
to E-cadherin. This inhibitory effect may be overcome at
higher cell densities because cells are forced into contacts
and there is sufficient E-cadherin bound to endogenous
b-catenin to function in cell–cell contact. However, cells
expressing DN90 b-catenin, which does bind a-catenin, ex-
hibited the same morphology as that of DN131 and DN151
b-catenin–expressing cells. This result indicates that ex-
pression of NH2-terminal–deleted b-catenin affects colony
formation in low density cultures independently of the
binding of b-catenin to a-catenin. Furthermore, this phe-
notype correlates with the dominant colocalization of all
three NH2-terminal–deleted b-catenin mutant proteins with
APC protein in clusters at the ends of membrane protru-
sions. Previous studies have shown that these APC protein
clusters localize to the ends of microtubules, and that this
localization is independent of the actin cytoskeleton
(Näthke et al., 1996). A role of clusters of APC protein in
cell migration and/or early contact formation has been
suggested (Näthke et al., 1996). Based upon the results of
the present study, we suggest that stable binding of b-cate-
nin to APC protein may affect a function of APC protein
in these clusters in microtubule organization and/or cell
migration. Thus, in low density cultures, altered migratory
behavior of cells may reduce the time and/or number of in-
tercellular contacts that enable cells to initiate stable cell–
cell adhesion, thereby giving rise to the observed defect in
colony formation. Furthermore, APC protein may be di-
rectly involved in the initiation of stable adhesion between
extending membranes of these cells (Näthke et al., 1996).
A detailed analysis of the role of the APC/b-catenin com-
plex underlying this phenotype is currently under investi-
gation.
Role of b-Catenin in Signaling Pathways and 
Embryonic Development
NH2-terminal–deleted  b-catenin mutant proteins have
been used to study the function of b-catenin in cell signal-
ing during embryonic development (Fagotto et al., 1996;
Funayama et al., 1995). In Drosophila, the b-catenin ho-
mologue armadillo was originally identified through its
role in transduction of the wingless/Wnt cell–cell signal
that mediates cell fate determination (Noordermeer et al.,
1994; Peifer et al., 1991; Peifer and Wieschaus, 1990; Sieg-
fried et al., 1994). In vertebrates, the wingless/Wnt signal-
ing pathway may be involved in the formation of the
dorsal-ventral axis during Xenopus embryogenesis, and
b-catenin seems to be a downstream component of this
pathway (Cui et al., 1995; Funayama et al., 1995; Heasman
et al., 1994; McCrea et al., 1993; Sokol et al., 1991). The
cellular mechanisms by which b-catenin receives or trans-
mits the wingless/Wnt signal are not well understood.
There is evidence that b-catenin has distinct roles in Wing-
less/Wnt signaling and cell adhesion, and that b-catenin
binding to cadherin antagonizes its signaling function (Cox
et al., 1996; Fagotto et al., 1996; Orsulic and Peifer, 1996).
In contrast to these results, ectopic Wnt expression in
mammalian cell lines leads to stabilization of b-catenin or
its homologue plakoglobin in the cadherin/catenin com-
plex and to increased adhesion (Bradley et al., 1993; Hinck
et al., 1994b). Ectopic expression of NH2-terminal–deleted
b-catenin mutant proteins similar to the ones used in this
study or of b-catenin with a mutated GSK3b phosphoryla-
tion site induced formation of a secondary dorsal body
axis in Xenopus embryos (Fagotto et al., 1996; Funayama
et al., 1995; Guger and Gumbiner, 1995; Yost et al., 1996).
These investigators noted that mutant b-catenin protein
was found in the nucleus. Yost et al. (1996) showed also
that inhibition of GSK3b by overexpression of a dominant
negative mutant causes nuclear localization of endogenous
b-catenin in Xenopus embryos. This localization may be
important for regulating cell fate determination at the
gene transcription level.
In this study, we have shown that mutant b-catenin pro-
teins form stable complexes with cadherin and APC pro-
tein. Although we have not directly analyzed the function
of endogenous b-catenin in APC protein complexes, our
results indicate strongly that a change in the dynamics of
b-catenin binding to APC protein resulting in stabilization
of the b-catenin/APC protein complex coincides with al-
terations in cell adhesion, migration, and morphology.
Given the possibility that one function of APC protein is
in regulating cell migration (Näthke et al., 1996), we sug-
gest that the dynamics of b-catenin binding to APC pro-
tein plays a key role in regulating APC protein function in
these events during complex cell movements. In support of
this idea, we have shown recently (Pollack, A., A. Barth,Barth et al. Expression of b-Catenin Mutant Proteins in MDCK Cells 705
W.J. Nelson, and K.E. Mostov, manuscript submitted for
publication) that expression of these mutant b-catenins in-
hibits hepatocyte growth factor/scatter factor–induced tubu-
logenesis of MDCK cysts. The initial stage of tubulogene-
sis involves migration of long cell extensions from the
cyst into the surrounding matrix; subsequently, these ex-
tensions reorganize into tubules. Expression of NH2-ter-
minal–deleted b-catenin inhibits formation of these cell
extensions and subsequent tubule formation. Significantly,
mutant b-catenin and APC protein colocalize prominently
at the tips of short membrane extensions that do not mi-
grate further. Precise control of cell–cell adhesion and mi-
gration is important during complex morphogenetic pro-
cesses such as gastrulation and neurulation. Thus, in
addition to affecting signaling pathways, b-catenin mutant
proteins may alter morphogenetic movements of cells by
impairing the functions of E-cadherin and/or APC protein
in cell adhesion and migration.
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